Short‐term changes in left and right systolic function following ferric carboxymaltose: a substudy of the Myocardial‐IRON trial

AIMS: The mechanisms underlying the beneficial effect of ferric carboxymaltose (FCM) in patients with heart failure (HF) and iron deficiency (ID) have not been completely characterized. The Myocardial‐IRON trial was a double‐blind, randomized trial that evaluated myocardial iron repletion following...

Descripción completa

Detalles Bibliográficos
Autores principales: Santas, Enrique, Miñana, Gema, Cardells, Ingrid, Palau, Patricia, Llàcer, Pau, Fácila, Lorenzo, Almenar, Luis, López‐Lereu, Maria P., Monmeneu, Jose V., Sanchis, Juan, Maceira, Alicia M., Bayés‐Genís, Antoni, Núñez, Julio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754736/
https://www.ncbi.nlm.nih.gov/pubmed/33040491
http://dx.doi.org/10.1002/ehf2.13053

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754736/
https://www.ncbi.nlm.nih.gov/pubmed/33040491
http://dx.doi.org/10.1002/ehf2.13053

Ejemplares similares